BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 17, 2006
View Archived Issues
CV Therapeutics Brings In $85.5M Via Public Offering
Two days after reporting plans for a public offering, CV Therapeutics Inc. raised $85.5 million, selling more shares than originally intended but at a lower price. (BioWorld Today)
Read More
Speedel Gains Rights To SPP200; Abbott Declines
Read More
Sirion Building Ophthalmic Pipeline Via Sytera Merger
Read More
TolerRx Round Gets $35.6M For Type I Diabetes Antibody
Read More
Other News To Note
Read More